Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports from M. Kimura and co-researchers add new data to research in breast cancer
July 24th, 2008
In this recent report published in the journal Anticancer Research, researchers in Gunma, Japan conducted a study "To determine the efficacy of preoperative weekly paclitaxel for patients with operable breast cancer tumors greater than 3 cm. Paclitaxel 80 mg/m(2) weekly x 3 times every 4 weeks for 3 cycles was administered to 53 patients." "Twnty-two patients were stage 11, 26 stage III, 5 stage IV. Median age (range) was 53 (24-73)years, and 32 patients were negative for estrogen receptor. Thirteen patients showed HER2 overexpression. Eligible cases composed of 53 patients for evaluation of response. Seven patients had a clinical complete response and 29...
Source: Women's Health Weekly (2008-07-24)
|
